H Kropp

3.5k total citations · 1 hit paper
35 papers, 2.9k citations indexed

About

H Kropp is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, H Kropp has authored 35 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 14 papers in Molecular Medicine and 10 papers in Infectious Diseases. Recurrent topics in H Kropp's work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Antibiotic Resistance in Bacteria (14 papers) and Antifungal resistance and susceptibility (5 papers). H Kropp is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (16 papers), Antibiotic Resistance in Bacteria (14 papers) and Antifungal resistance and susceptibility (5 papers). H Kropp collaborates with scholars based in United States, Sweden and Japan. H Kropp's co-authors include Frederick M. Kahan, Jon G. Sundelof, Jean S. Kahan, Patrick J. Cassidy, Jerome Birnbaum, Richard Hajdu, J. J. Jackson, J. S. Macdonald, George K. Abruzzo and Christopher Gill and has published in prestigious journals such as Nature, Clinical Infectious Diseases and Annals of the New York Academy of Sciences.

In The Last Decade

H Kropp

34 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN)

1974 636 citations Frederick M. Kahan, Jean S. Kahan et al. Annals of the New York Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H Kropp United States	19	1.2k	1.0k	818	713	662	35	2.9k
J. M. Andrews United Kingdom	33	1.8k 1.5×	1.5k 1.4×	1.3k 1.6×	655 0.9×	552 0.8×	101	3.3k
Thomas D. Gootz United States	36	1.2k 1.0×	1.5k 1.5×	661 0.8×	490 0.7×	1.3k 2.0×	60	3.4k
Kwung P. Fu United States	28	1.5k 1.2×	1.2k 1.2×	568 0.7×	415 0.6×	500 0.8×	52	2.5k
G. N. Rolinson United Kingdom	31	1.6k 1.3×	987 1.0×	535 0.7×	749 1.1×	986 1.5×	77	3.4k
A. Dalhoff Germany	31	1.6k 1.3×	1.1k 1.0×	1.1k 1.4×	488 0.7×	570 0.9×	108	3.0k
N H Georgopapadakou United States	30	1.1k 0.9×	979 0.9×	732 0.9×	1.1k 1.6×	1.5k 2.3×	86	3.8k
Frederick M. Kahan United States	16	1.5k 1.3×	1.4k 1.4×	698 0.9×	380 0.5×	1.1k 1.6×	17	3.6k
D P Bonner United States	30	1.1k 0.9×	929 0.9×	669 0.8×	824 1.2×	764 1.2×	72	2.9k
A. Bryskier France	30	809 0.7×	730 0.7×	1.0k 1.2×	796 1.1×	591 0.9×	121	2.4k
N X Chin United States	28	1.4k 1.1×	979 0.9×	759 0.9×	633 0.9×	412 0.6×	62	2.3k

Countries citing papers authored by H Kropp

Since Specialization

Citations

This map shows the geographic impact of H Kropp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Kropp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Kropp more than expected).

Fields of papers citing papers by H Kropp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Kropp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Kropp. The network helps show where H Kropp may publish in the future.

Co-authorship network of co-authors of H Kropp

This figure shows the co-authorship network connecting the top 25 collaborators of H Kropp. A scholar is included among the top collaborators of H Kropp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Kropp. H Kropp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gill, Charles, Jesse J. Jackson, Barbara A. Pelak, et al.. (1998). In Vivo Activity and Pharmacokinetic Evaluation of a Novel Long-Acting Carbapenem Antibiotic, MK-826 (L-749,345). Antimicrobial Agents and Chemotherapy. 42(8). 1996–2001. 57 indexed citations

Smith, Jeffrey G., L. Kong, George K. Abruzzo, et al.. (1997). Evaluation of Experimental Therapeutics in a New Mouse Model ofHelicobacter felisUtilizing 16S rRNA Polymerase Chain Reaction for Detection. Scandinavian Journal of Gastroenterology. 32(4). 297–302. 6 indexed citations

Hajdu, Richard, Jon G. Sundelof, Barbara A. Pelak, et al.. (1997). Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872). Antimicrobial Agents and Chemotherapy. 41(11). 2339–2344. 141 indexed citations

Kong, L., Jeffrey G. Smith, David Bramhill, et al.. (1996). A sensitive and specific PCR method to detect Helicobacter felis in a conventional mouse model. Clinical and Diagnostic Laboratory Immunology. 3(1). 73–78. 13 indexed citations

Jackson, Jesse J. & H Kropp. (1996). Differences in mode of action of (β-lactam antibiotics influence morphology, LPS release and in vivo antibiotic efficacy. Journal of Endotoxin Research. 3(3). 201–218. 45 indexed citations

Bartizal, Ken, et al.. (1995). In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373. Antimicrobial Agents and Chemotherapy. 39(5). 1070–1076. 47 indexed citations

DiNinno, Frank, et al.. (1995). The discovery and synthesis of 2-biphenylcarbapenems active against methicillin resistant staphylococci. Bioorganic & Medicinal Chemistry Letters. 5(9). 945–948. 7 indexed citations

Kropp, H, et al.. (1995). Quantitative variations in beta-lactam antibiotic released endotoxin from Pseudomonas aeruginosa: in-vivo relevance.. PubMed. 392. 235–51. 1 indexed citations

Gill, Charles, George K. Abruzzo, Amy Flattery, et al.. (1995). In vivo Evaluation of Three Acid-stable Azalide Compounds, L-701,677, L-708,299 and L-708,365 Compared to Erythromycin, Azithromycin and Clarithromycin.. The Journal of Antibiotics. 48(10). 1141–1147. 6 indexed citations

10.

Abruzzo, George K., Amy Flattery, Christopher Gill, et al.. (1995). Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrobial Agents and Chemotherapy. 39(5). 1077–1081. 67 indexed citations

11.

Jackson, J. J. & H Kropp. (1993). Reply. The Journal of Infectious Diseases. 167(3). 775–777. 2 indexed citations

12.

Balkovec, James M., Regina M. Black, Milton L. Hammond, et al.. (1992). Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP). Journal of Medicinal Chemistry. 35(1). 194–198. 55 indexed citations

13.

Jackson, J. J. & H Kropp. (1992). ss-Lactam Antibiotic-Induced Release of Free Endotoxin: In Vitro Comparison of Penicillin-Binding Protein (PBP) 2-Specific Imipenem and PBP 3-Specific Ceftazidime. The Journal of Infectious Diseases. 165(6). 1033–1041. 152 indexed citations

14.

Darland, Gary, Richard Hajdu, H Kropp, et al.. (1986). Oxidative and defluorinative metabolism of fludalanine, 2-2H-3-fluoro-D-alanine.. Drug Metabolism and Disposition. 14(6). 668–673. 15 indexed citations

15.

Birnbaum, Jerome, Frederick M. Kahan, H Kropp, & J. S. Macdonald. (1985). Carbapenems, a new class of beta-lactam antibiotics. The American Journal of Medicine. 78(6). 3–21. 216 indexed citations

16.

Kropp, H, Jon G. Sundelof, Jean S. Kahan, Frederick M. Kahan, & Jerome Birnbaum. (1980). MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities. Antimicrobial Agents and Chemotherapy. 17(6). 993–1000. 162 indexed citations

17.

Kahan, Frederick M., Jean S. Kahan, Patrick J. Cassidy, & H Kropp. (1974). THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN). Annals of the New York Academy of Sciences. 235(1). 364–386. 636 indexed citations breakdown →

18.

Franke, Ingo, et al.. (1973). [A so-called coumarin necrosis in a child].. PubMed. 121(2). 68–71. 1 indexed citations

19.

Kropp, H, et al.. (1969). Phosphonomycin. V. Evaluation in mice.. PubMed. 9. 310–5. 9 indexed citations

20.

Kropp, H, et al.. (1952). [Determination of sensitivity of bacteria against chemotherapeutics and antibiotics in bacterial infections].. PubMed. 2(3). 103–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact